Specifications

• Protein/Peptide Type:
  Recombinant
• Source:
  HEK293 cells
• Species:
  Human
• Storage Conditions:
  –20 °C
• Endotoxin Content:
  Less than 1.0 EU per μg by the LAL method.
• Biological Activity:
  Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.; Measured by its binding ability in a functional ELISA. Immobilized Anti-Human LAG3 MAb, Human IgG1 at 2 μg/mL (100 μL/well) can bind Biotinylated Human LAG-3, Fc,Avitag (Cat. No. LA3-H82Fb) with a linear range of 0.1-3 ng/mL (QC tested).; Serial dilutions of Anti-LAG3, Neutralizing Antibody were added into Human FGL1, His Tag (Cat. No. FG1-H52Hy): Biotinylated Human LAG-3, Fc,Avitag (Cat. No. LA3-H82Fb) binding reactions. The half maximal inhibitory concentration (IC50) is 0.16695 μg/mL (Routinely tested).
• Gene ID:
  P18627-1
• Carrier-Free:
  Y
• Protease-free:
  Y
• Animal-Free:
  Y
• Protein Synonyms:
  FDC|CD223|LAG3
• Protein/Peptide Name:
  LAG-3
• Purity:
  >95%
• Molecular Weight:
  75.0 kDa
• Endotoxin Level:
  Low
• Formulation:
  Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.
• Nuclease-free:
  Y
• Shipping Temperature:
  Powder,RT